Tel: +47 76 06 09 30
Address Leknes: Lofoten Bio Centre, Storeidøya 60, 8370 Leknes
Address Ås: Christian Magnus Falsens vei 18, 1430 Ås
COO
Brink is a graduate in economy from UCL in Denmark. He has 9 years of experience from international banking, he has been involved in the establishment of several large companies and holds several board positions. Brink was hired as COO of ACD Pharma in march 2021 too lead the company through commercialisation and the establishment of the company´s bacteriophage factory in Lofoten.
PhD, R&D operations manager
Frantzen studied bioengineering at the UiT Arctic University of Norway, and did his MSc and PhD in microbiology at the Norwegian University of Life Sciences. His doctoral thesis covered the development and use of bioinformatics for analysing bacteria and bacteriophages. He joined ACD Pharma as a researcher after receiving his PhD, and has been R&D operations manager for the company since 2019.
MSc, senior engineer
Bårdsen has been with ACD since graduating as a microbiologist in 2013. He is a “jack of all trades” in the laboratory, with the emphasis on testing new methods and isolating new bacteriophages.
Bårdsen holds an MSc in microbiology, having studied at the Norwegian University of Life Sciences, the Norwegian University of Science and Technology and the University of Saskatchewan, Canada.
MSc, research engineer
Ingrid Støtvig joined the ACD Pharma research team in 2022. She has a Master´s of Science degree in biomedicine from UiT The Arctic University of Norway. She is knowledgeable in molecular methods and applied medical genetics.
Senior Development Scientist
Kileng studied molecular biology at The University of Bergen and did his PhD at UiT The Arctic University of Norway on the interaction between the immune system in Atlantic salmon and the ISA virus. As a post doctor at Nofima he researched similar interactions between the immune system in Atlantic cod and the Nodavirus.
MSc, research engineer
Hannah has a Master of Science in biotechnology from The Norwgeian University of Life Sciences and worked for Oslo University Hospital before joining ACD Pharma in december 2022. She is experienced in several molecular-biologic og biochemical methods.
MSc, research engineer
andreas.damgaard@acdpharma.com
Damgaard has a Master of Science degree in Biochemistry and molecular biology from the University of Southern Denmark. He has worked on multiple projects focusing on both bacteriophage isolation, bacteriophage characterisation and bacterial defence mechanisms against bacteriophage infections. He joined ACD Pharma as a research engineer in August 2023, and works on the screening process, analysis, and development of bacteriophage-based products.